ATC code J06

0 views
ATC code J06 Immune sera and immunoglobulins is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup J06 is part of the anatomical group J Antiinfectives for systemic use.

ATC code J06 Immune sera and immunoglobulins is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup J06 is part of the anatomical group J Antiinfectives for systemic use.[4]

National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

J06A Immune sera

[edit]

J06AA Immune sera

[edit]
J06AA01 Diphtheria antitoxin J06AA02 Tetanus antitoxin J06AA03 Snake venom antiserum J06AA04 Botulinum antitoxin J06AA05 Gas-gangrene sera J06AA06 Rabies serum

J06B Immunoglobulins

[edit]

J06BA Immunoglobulins, normal human

[edit]
J06BA01 Immunoglobulins, normal human, for extravascular administration J06BA02 Immunoglobulins, normal human, for intravascular administration

J06BB Specific immunoglobulins

[edit]
J06BB01 Anti-D (rh) immunoglobulin J06BB02 Tetanus immunoglobulin J06BB03 Varicella/zoster immunoglobulin J06BB04 Hepatitis B immunoglobulin J06BB05 Rabies immunoglobulin J06BB06 Rubella immunoglobulin J06BB07 Vaccinia immunoglobulin J06BB08 Staphylococcus immunoglobulin J06BB09 Cytomegalovirus immunoglobulin J06BB10 Diphtheria immunoglobulin J06BB11 Hepatitis A immunoglobulin J06BB12 Encephalitis, tick-borne immunoglobulin J06BB13 Pertussis immunoglobulin J06BB14 Morbilli immunoglobulin J06BB15 Parotitis immunoglobulin J06BB19 Anthrax immunoglobulin J06BB30 Combinations

J06BC Antibacterial monoclonal antibodies

[edit]
J06BC01 Nebacumab J06BC02 Raxibacumab J06BC03 Bezlotoxumab J06BC04 Obiltoxaximab

J06BD Antiviral monoclonal antibodies

[edit]
J06BD01 Palivizumab J06BD02 Motavizumab J06BD03 Tixagevimab and cilgavimab J06BD04 Ansuvimab J06BD05 Sotrovimab J06BD06 Regdanvimab J06BD07 Casirivimab and imdevimab J06BD08 Nirsevimab J06BD09 Sipavibart J06BD10 Clesrovimab J06BD11 Libevitug

See also

[edit]
  • Immune sera and immunoglobulins for veterinary use are in the ATCvet group QI.

References

[edit]
  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code J06". WHO Collaborating Centre for Drug Statistics Methodology.

This article is sourced from Wikipedia. Content is available under the Creative Commons Attribution-ShareAlike License.